BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakraborty C, Bhattacharya M, Mallick B, Sharma AR, Lee SS, Agoramoorthy G. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol 2021;14:225-38. [PMID: 33423554 DOI: 10.1080/17512433.2021.1874348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta Y, Savytskyi OV, Coban M, Venugopal A, Pleqi V, Weber CA, Chitale R, Durvasula R, Hopkins C, Kempaiah P, Caulfield TR. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. Mol Aspects Med 2022;91:101151. [PMID: 36371228 DOI: 10.1016/j.mam.2022.101151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chakraborty C, Saha A, Bhattacharya M, Dhama K, Agoramoorthy G. Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants. Mol Ther Nucleic Acids 2023;31:437-9. [PMID: 36817724 DOI: 10.1016/j.omtn.2023.01.013] [Reference Citation Analysis]
3 Alam A, Agrawal GP, Khan S, Khalilullah H, Saifullah MK, Arshad MF. Towards the discovery of potential RdRp inhibitors for the treatment of COVID-19: structure guided virtual screening, computational ADME and molecular dynamics study. Struct Chem 2022;:1-15. [PMID: 35669792 DOI: 10.1007/s11224-022-01976-2] [Reference Citation Analysis]
4 Bhattacharya M, Sharma AR, Ghosh P, Patra P, Mallick B, Patra BC, Lee SS, Chakraborty C. TN strain proteome mediated therapeutic target mapping and multi-epitopic peptide-based vaccine development for Mycobacterium leprae. Infect Genet Evol 2022;99:105245. [PMID: 35150891 DOI: 10.1016/j.meegid.2022.105245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations. Front Immunol 2022;13:801522. [PMID: 35222380 DOI: 10.3389/fimmu.2022.801522] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
6 Chakraborty C, Sharma AR, Bhattacharya M, Zayed H, Lee SS. Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection. Front Immunol 2021;12:724936. [PMID: 34975833 DOI: 10.3389/fimmu.2021.724936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Pérez-Pérez MJ, Saiz JC, Priego EM, Martín-Acebes MA. Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host? ACS Med Chem Lett 2022;13:5-10. [PMID: 35059112 DOI: 10.1021/acsmedchemlett.1c00617] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies. Front Pharmacol 2021;12:704205. [PMID: 34867318 DOI: 10.3389/fphar.2021.704205] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
9 Chakraborty C, Bhattacharya M, Sharma AR. Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance. Curr Opin Pharmacol 2021;62:64-73. [PMID: 34920267 DOI: 10.1016/j.coph.2021.11.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
10 Rajpoot S, Ohishi T, Kumar A, Pan Q, Banerjee S, Zhang KYJ, Baig MS. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs R D 2021;21:273-83. [PMID: 34324175 DOI: 10.1007/s40268-021-00357-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Shiryaev VA, Klimochkin YN. Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors. Russ J Org Chem 2021;57:730-767. [DOI: 10.1134/s107042802105002x] [Reference Citation Analysis]